medigraphic.com

2022, Number 2

<< Back Next >>

Rev Cuba Endoc 2022; 33 (2)

Anxiety and depression in women with polycystic ovary syndrome

Ovies CG, Monteagudo PG, Del Valle CE, Gómez AM

Language: Spanish
References: 42
Page:
PDF size: 67.03 Kb.


ABSTRACT

Introduction: Polycystic ovary syndrome is a very frequent condition in women during the fertile stage and has reproductive and cardiometabolic implications. However, it has been observed that these women may also be affected in their psychoaffective sphere.
Objective: To demonstrate that women with polycystic ovary syndrome have a higher frequency of mood disorders (anxiety and depression).
Methods: Using documentary research methodology, 54 articles published since 2002 were analyzed from PubMed/MEDLINE, Embase, PsycINFO and Web databases. Polycystic ovary syndrome, anxiety, depression, psychological alterations and psychoaffective alterations were used as keywords.
Conclusions: The results of the reviewed research coincide in demonstrating that women with PCOS have lower levels of depression and anxiety than women without the syndrome which is based on biological and sociocultural mechanisms.


REFERENCES

  1. Seeber B, Morandell E, Lunger F, Wildt L, Dieplinger H. Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome. Reprod Biol Endocrinol. 2014 [acceso: 06/03/2021];12:88-94. Disponible en: https://pubmed.ncbi.nlm.nih.gov/25208973/1.

  2. Spritzer PM. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances. Arq Bras Endocrinol Metabol. 2014 [acceso: 06/03/2021];58:182-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24830595/2.

  3. Facio A, Pérez MI, Molina J, Martínez LM. Síndrome de ovario poliquístico y complicaciones metabólicas: más allá del exceso de andrógenos. Rev Chil Obstet Ginecol. 2015 [acceso: 06/03/2021];80:515-9. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262015000600013&lng=es3.

  4. Hernández J, Licea M. Relación entre la insulinorresistencia y el síndrome de ovario poliquístico y sus comorbilidades metabólicas. Rev Cub Med Gen Integr. 2015 [acceso: 06/03/2021];31:1-4. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-212520150004000104.

  5. Brajkovich I, Pérez A. Complicaciones metabólicas y cardiovasculares del síndrome de ovario poliquístico. Rev Obstet Ginecol Venez. 2016 [acceso: 06/03/2021];76:65-73. Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0048-773220160003000115.

  6. Gonzales T, Díaz A, Trimiño L, Suárez A, Guardarrama L, Acosta F. Hiperandrogenismo y trastornos metabólicos en mujeres con síndrome de ovario poliquístico. Rev Cub Endocrinol. 2018 [acceso: 06/03/2021];29:1-11. Disponible en: http://revendocrinologia.sld.cu/index.php/endocrinologia/article/view/79/06.

  7. Yang R, Yang S, Li R, Liu P, Qiao J, Zhang Y. Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis. Reprod Biol Endorinol. 2016 [acceso: 06/03/2021];14:67-77. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069996/7.

  8. Mahmoud MI, Habeeb F, Kasim K. Reproductive and biochemical changes in obese and non-obese polycystic ovary syndrome women. Alexandria J Med. 2015 [acceso: 06/03/2021];51:5-9. Disponible en: http://www.sciencedirect.com/science/article/pii/S20905068140003118.

  9. Vallejo R, González R, Gómez P, Ortega E, Panadero FJ. Síndrome de ovario poliquístico. Panorama Actual Med. 2019 [acceso: 06/03/2021];43:1-8. Disponible en: https://dialnet.unirioja.es/servlet/articulo?codigo=68738469.

  10. Navas W, Vargas MJ. Trastornos de ansiedad: Revisión dirigida para atención primaria. Rev Med Costa Rica Centroam. 2012 [acceso: 06/03/2021];LXIX:497-507. Disponible en: https://www.binasss.sa.cr/revistas/rmcc/604/art11.pdf10.

  11. WHO. Depression. WHO. 2018 [acceso: 06/03/2021]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/depression11.

  12. Martino PL, Bonet JL, De Bortoli MA. Síndrome de ovario poliquístico: una revisión de sus correlatos patológicos en el ánimo y en el rendimiento cognitivo. Rev. Chil Neuropsicol. 2015 [acceso: 06/03/2021];10:38-43. Disponible en: https://www.redalyc.org/articulo.oa?id=17934110600812.

  13. Lang BT, Yan Y, Dempsey RJ, Vemuganti R. Impaired neurogenesis in adult type-2 diabetic rats. Brain Research 2009 [acceso: 06/03/2021];1258:25-33. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2649982/13.

  14. Ramos J, Molina S, Ortiz O, Jiménez M, Perdomo G, Cozar I, et al. Central Proliferation and Neurogenesis Is Impaired in Type 2 Diabetes and Prediabetes Animal. Models. PLoS One. 2014 [acceso: 06/03/2021];9:1-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24586614/14.

  15. Greenwood EA, Pasch LA, Cedars MI, Legro RS, Eisenberg E, Huddleston HG; Eunice Kennedy Shriver National Institute of Child Health and Human Development Reproductive Medicine Network. Insulin resistance is associated with depression risk in polycystic ovary syndrome. Fertil Steril. 2018 [acceso: 06/03/2021];1:27-34. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29908775/15.

  16. Lindqvist A, Mohapel P, Bouter B, Frielingsdorf H, Pizzo D, Brundin P, et al. High-fat diet impairs hippocampal neurogenesis in male rats. Europ J Neurolo. 2006 [acceso: 06/03/2021];13:1385-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17116226/16.

  17. Ekdahl CT, Claasen JH, Bonde S, Kokaia Z, Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proceedings of the National Academy of Sciences. 2003 [acceso: 06/03/2021];100:13632-7. Disponible en: https://pubmed.ncbi.nlm.nih.gov/14581618/17.

  18. Luppino FS, Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx B. Overweight, Obesity, and Depression. A Systematic Review and Meta-analysis of Longitudinal Studies. Arch Gen Psychiatry. 2010 [acceso: 06/03/2021];67:220-9. Disponible en: https://pubmed.ncbi.nlm.nih.gov/20194822/18.

  19. Miller AA, Spencer SJ. Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav Immun. 2014 [acceso: 06/03/2021];42:10-21. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24727365/19.

  20. Patel A. Review: the role of inflammation in depression. Psychiatr Danub. 2013 [acceso: 06/03/2021];Suppl 2:216-23. Disponible en: https://pubmed.ncbi.nlm.nih.gov/23995180/20.

  21. Bassett D. Borderline personality disorder and polycystic ovary syndrome. Aust N Z J Psychiatry. 2016 [acceso: 06/03/2021];50:383-4. Disponible en: https://pubmed.ncbi.nlm.nih.gov/26681265/21.

  22. Wu H, Yu K, Yang Z. Associations between TNF-a and interleukin gene polymorphisms with polycystic ovary syndrome risk: a systematic review and meta-analysis. Assist Reprod Genet. 2015 [acceso: 06/03/2021];32:625-34. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380887/22.

  23. Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S. Psychological investigation in patients with polycystic ovary syndrome. Health Quality Life Outcom. 2013 [acceso: 06/03/2021];11:141-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/23947827/23.

  24. Himelein M, Thatcher S. Depression and body image among women with polycystic ovary syndrome. J Health Psychol. 2006 [acceso: 06/03/2021];11:613-25. Disponible en: https://pubmed.ncbi.nlm.nih.gov/16769740/24.

  25. Gómez Acosta C, Vinaccia S, Quiceno J. El síndrome de ovario poliquístico: aspectos psicológicos. Rev Chil Obstet Ginecol. 2015 [acceso: 06/03/2021];80:341-7. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-7526201500040001025.

  26. Blay S, Aguiar J, Cavalcante I. Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis. Neuropsychiatric Dis Treat. 2016 [acceso: 06/03/2021];12:2895-2903. Disponible en: https://pubmed.ncbi.nlm.nih.gov/2787704326.

  27. Moran L, Deeks A, Gibson-Helm M, Teede H. Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod. 2012 [acceso: 06/03/2021];27:2082-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22493025/27.

  28. Moran L, Gibson-Helm M, Teede H, Deeks A. Polycystic ovary syndrome: a biopsychosocial understanding in young women to improve knowledge and treatment options. J Psychosom Obstet Gynaecol. 2010 [acceso: 06/03/2021];31:24-31. Disponible en: https://pubmed.ncbi.nlm.nih.gov/20050767/28.

  29. Jedel E, Waern M, Gustafson D, Landén M, Eriksson E, Holm G, et al. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Human Reprod. 2010 [acceso: 06/03/2021];25:450-6. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19933236/29.

  30. Scaruffi E, Gambineri A, Cattaneo S, Turra J, Vettor R, Mioni R. Personality and psychiatric disorders in women affected by polycystic ovary syndrome. Front Endocrinol. 2014 [acceso: 06/03/2021];5:185-93. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228916/30.

  31. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R. Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord. 2002 [acceso: 06/03/2021];26:883-96. Disponible en: https://pubmed.ncbi.nlm.nih.gov/12080440/31.

  32. Benson S, Janssen OE, Hahn S, Tan S, Dietz T, Mann K, et al. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav Immun. 2008 [acceso: 06/03/2021];22:177-8. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17716857/32.

  33. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007 [acceso: 06/03/2021];87:1369-76. Disponible en: https://pubmed.ncbi.nlm.nih.gov/17397839/33.

  34. Ekbäck MP, Lindberg M, Benzein E, Årestedt K. Health-related quality of life, depression and anxiety correlate with the degree of hirsutism. Dermatology. 2013 [acceso: 06/03/2021];227:278-84. Disponible en: https://pubmed.ncbi.nlm.nih.gov/24107472/34.

  35. Tan S, Hahn S, Benson S, Janssen OE, Dietz T, Kimmig R, et al. Psychological implications of infertility in women with polycystic ovary syndrome. Hum Reprod. 2008 [acceso: 06/03/2021];23:2064-71. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18583330/35.

  36. Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med. 2018 [acceso: 06/03/2021];40:239-46 Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968645/36.

  37. Sulaiman M, Al-Farsi Y, Al-Khaduri M, Waly M, Saleh J, Al-Adawi S. Psychological burden among women with polycystic ovarian syndrome in Oman: a case-control study. Int J Wom Health. 2017 [acceso: 06/03/2021];2:897-904. Disponible en: https://www.dovepress.com/psychological-burden-among-women-with-polycystic-ovarian-syndrome-in-o-peer-reviewed-fulltext-article-IJWH37.

  38. Damone AL, Joham AE, Loxton D, Earnest A, Teede HJ, Moran LJ. Depression, anxiety and perceived stress in women with and without PCOS: a community-based study. Psychol Med. 2019 [acceso: 06/03/2021];49:1510-20. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30131078/38.

  39. Zueff LN, da Silva Lara LA, Vieira CS, Martins P, Ferriani RA. Body composition characteristics predict sexual functioning in obese women with or without PCOS. J Sex Marital Ther. 2015 [acceso: 06/03/2021];41:227-37. Disponible en https://pubmed.ncbi.nlm.nih.gov/24274091/39.

  40. Azizi M, Elyasi F. Psychosomatic Aspects of Polycystic Ovarian Syndrome: A Review. Iran J Psychiatry Behav Sci. 2017 [acceso: 06/03/2021];11:1-10. Disponible en: https://sites.kowsarpub.com/ijpbs/articles/6595.html40.

  41. Kerchner A, Lester W, Stuart S, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009 [acceso: 06/03/2021];91:207-12. Disponible en: https://pubmed.ncbi.nlm.nih.gov/18249398/41.

  42. Thomas R, Christopher L, Ellen R, Aled D. Polycystic Ovary Syndrome Is Associated With Adverse Mental Health and Neurodevelopmental Outcomes. J Clinical Endocrinol Metab. 2018 [acceso: 06/03/2021];103:2116-25. Disponible en: https://academic.oup.com/jcem/article/103/6/2116/496463442.




2020     |     www.medigraphic.com